Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Seminars in Diagnostic Pathology|August 1, 1987
Flow cytometry of transitional cell carcinoma of the urinary bladder: influence of prior local therapyB Têtu, R L Katz, S P Kalter, et al.
Cancer|October 15, 1987
Small cell carcinoma of the kidney. A clinicopathologic, immunohistochemical, and ultrastructural studyB Têtu, J Y Ro, A G Ayala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrenceC Pfister, L Moore, P Allard, et al.
Urology|March 30, 1999
Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapyT H van der Kwast, B Têtu, B Candas, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
[Incidence and risk factors of second primary cancers in patients treated for primary pharyngeal cancer]F Brochet, I Bairati, J Roy, et al.
The American Journal of Surgical Pathology|February 1, 1991
Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. A histopathologic and immunohistochemical studyB Têtu, J R Srigley, J C Boivin, et al.
The Journal of Urology|May 1, 1997
Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumorsM Grégoire, Y Fradet, F Meyer, et al.
The Journal of Pathology|April 21, 1999
Cycling activity of benign prostatic epithelial cells during long-term androgen blockade: evidence for self-renewal of luminal cellsT H van der Kwast, B Têtu, E R Suburu, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
[Prevention of second primary cancer with vitamin supplementation in patients treated for head and neck cancers]I Bairati, F Brochet, J Roy, et al.
Cancer Genetics and Cytogenetics|July 29, 2000
Establishment and characterization of a new cell line derived from a human primary breast carcinomaC S Wang, F Goulet, J Lavoie, et al.
Pageof 8